IPO Issue Details
Issue Price / Price Band₹662 per share (Fixed Price)
Face Value₹2 Per Share
Lot Size22 Shares per Lot
Total Issue Size1,54,65,861 shares (aggregating up to ₹1,023.54 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenMon, 15 Nov 2021
Subscription CloseWed, 17 Nov 2021
Anchor AllotmentFri, 12 Nov 2021
Basis of AllotmentTue, 23 Nov 2021
Initiation of RefundsWed, 24 Nov 2021
Credit of Shares to DematThu, 25 Nov 2021
Listing DateFri, 26 Nov 2021
UPI Mandate Deadline2021-11-17
Application & Investment Details
Retail — Min (1 Lots)₹14,564 — 22 shares
Retail — Max (13 Lots)₹189,332 (13 Lots)
HNI — Min (14 Lots)₹2,03,896 — 308 shares
Pre-IPO Promoter Holding5,09,40,420 shares
Post-IPO Promoter Holding5,32,06,281 shares
Fresh Issue Shares22,65,862 shares (aggregating up to ₹149.96 Cr)
Offer for Sale Shares1,31,99,999 shares of ₹2 (aggregating up to ₹873.58 Cr)
About Tarsons Products Ltd.
Tarsons Products Limited is a leading Indian life sciences company with more than three decades of experience in the production and supply of labware products. The company manufactures a range of quality labware products that helps advance scientific discovery and improve healthcare systems. The company's product portfolio is classified into three broad categories including consumables, reusables, and others. As of March 31, 2021, the company has a diversified product portfolio with over 1,700 SKUs across 300 products.Trason's products are used in various laboratories across research organizations, academic institutes, pharmaceutical companies, Contract Research Organizations (CRO), diagnostic companies, and hospitals. The company has many reputed institutes, medical labs, and hospitals as its key clients.Currently, the company has 5 manufacturing facilities located in West Bengal spread across approximately 20,000 sq. mts of area. The company has a strong distribution network across India comprising of over 141 authorized distributors as of March 31, 2021 and supplies its products to more than 40 countries.Competitive Strengths:Leading supplier of life sciences productsExtensive product offeringLarge addressable market of life sciences industryWell-equipped and automated manufacturing facilitiesStrong sales and distribution networkExperienced Promoter backed by a strong management team
Objects of the Issue
Tarsons Products Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 Repayment/prepayment of certain borrowings of our Company
78.54
2
2 Funding capital expenditure for the Proposed Expansion
62.00
3
3 General corporate purposes
1.62
Shareholding & Lock-in
Pre-IPO Promoter Holding
5,09,40,420 shares
Post-IPO Promoter Holding
5,32,06,281 shares
Lock-in Period (30%)December 23, 2021
Lock-in Period (50%)February 21, 2022